Total results651
Search criteria
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
ABCC9O60706ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2)Disease related genesFDA approved drug targetsHuman disease related genes15Atrial fibrillationCardiomyopathyIntellectual disabilityClinical-translation mediationFusion and delivery mediationImmune mediation10.53
ABCG2Q9UNQ0Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)Cancer-related genesCD markersEnzymes6Irritable bowel syndromeRheumatoid arthritisClinical-translation mediationFusion and delivery mediationMetabolism mediation10.53
ACHA2Q15822Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2)4Corneal diseaseDepressionGlaucomaClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.53
ACKR3P25106Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1)Cancer-related genesDisease related genesG-protein coupled receptors7AsthmaSolid tumour/cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.53
ADA2AP08913Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR)7Alzheimer diseaseAttention deficit hyperactivity disorderDementiaClinical-translation mediationFusion and delivery mediationImmune mediation10.53
ADCY5O95622Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)Disease related genesEnzymesHuman disease related genes12Intellectual disabilityClinical-translation mediationFusion and delivery mediationMetabolism mediation10.53
ADRB2P07550Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor)7AsthmaBladder disorderBreast cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.53
AGTR1P30556Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor)Disease related genesFDA approved drug targetsG-protein coupled receptors7Alzheimer diseaseArteries/arterioles disorderEssential hypertensionClinical-translation mediationFusion and delivery mediationImmune mediation10.53
AGTR2P50052Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2 receptor)7HypertensionNeuropathySecondary hypertensionClinical-translation mediationImmune mediationReceptor-signaling mediation10.53
AMPEQ07075Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249)CD markersEnzymesPlasma proteins1HypertensionClinical-translation mediationFusion and delivery mediationMetabolism mediation10.53